Phase I, open-label, single-center, multiple-dose, dose-escalation clinical study of SUO11248 (Sunitinib) in subjects with high-risk prostate cancer who have elected to undergo radical prostatectomy Allan J. PantuckNazy ZomorodianArie S. Belldegrun Clinical Trials Report 30 May 2007 Pages: 3 - 4
Classical pathology versus molecular pathology in renal cell carcinoma Peggy Soung SullivanJianYu RaoRichard J. Cote OriginalPaper 30 May 2007 Pages: 5 - 11
Laparoscopic renal surgery for benign disease Joseph C. LiaoAlberto BredaPeter G. Schulam OriginalPaper 30 May 2007 Pages: 12 - 18
Adjuvant therapy for high-risk renal cell carcinoma patients David A. KunkleNaomi B. HaasRobert G. Uzzo OriginalPaper 30 May 2007 Pages: 19 - 30
Oncologic outcomes for ablative therapy of kidney cancer Sangtae ParkJeffrey A. CadedduW. Bruce Shingleton OriginalPaper 30 May 2007 Pages: 31 - 37
Contemporary imaging modalities for the surveillance of patients with renal cell carcinoma Matthew K. TollefsonNaoki TakahashiBradley C. Leibovich OriginalPaper 30 May 2007 Pages: 38 - 43
New laser treatment approaches for benign prostatic hyperplasia Nathaniel M. Fried OriginalPaper 30 May 2007 Pages: 47 - 52
Therapeutic options in advanced prostate cancer: Present and future Richard D. SoweryAlan I. SoMartin E. Gleave OriginalPaper 30 May 2007 Pages: 53 - 59
Nocturnal bladder emptying for reversing urinary tract deterioration due to neurogenic bladder Stephen CanonSeth AlpertStephen A. Koff OriginalPaper 30 May 2007 Pages: 60 - 65
Male overactive bladder: The role of urodynamics and anticholinergics Scott MacDiarmidAlexandra Rogers OriginalPaper 30 May 2007 Pages: 66 - 73
Diagnosis and management of adrenal cortical carcinoma Brant R. Fulmer OriginalPaper 30 May 2007 Pages: 77 - 82
Extra-adrenal pheochromocytoma: Diagnosis and management Grant I. S. DisickMichael A. Palese OriginalPaper 30 May 2007 Pages: 83 - 88
